These increased plasma levels of APE1/Ref-1 detected in the WD group were suppressed by treatment with atorvastatin (11.36 ± 2.17 ng/mL for WD vs. 3.54 ± 0.52 ng/mL for WD + statin) (Figure 5A). This evidence concerns the gene APEX1 and Wilson disease.